UPDATE : Friday, December 13, 2019
상단여백
AbbVie’s Venclexta nears insurance benefit by Kim Eun-young 2019-12-06 16:35
Syntekabio, CHA Hospital to co-develop immunotherapy by Lee Han-soo 2019-12-06 16:32
Medpacto vows to become global company specializing in biomarker-based drugs by Lee Han-soo 2019-12-06 15:03
Petitioner demands broader benefit for ovarian cancer drug Zejula by Song Soo-youn 2019-12-06 15:02
China OKs Humedix's hyaluronic acid filler by Lee Han-soo 2019-12-06 15:02
라인
Foreign trainee doctors to get easier extension of training by Kwak Sung-sun 2019-12-06 12:42
‘Endogenous T cells have high potential of treating blood, solid tumors’ by Lee Han-soo 2019-12-06 12:41
Korea exports health insurance system to Bahrain by Kwak Sung-sun 2019-12-05 16:12
‘Lynparza raises value of precision medicine as anticancer treatment’ by Kim Yun-mi 2019-12-05 16:05
Celltrion 1st Korean biopharmaceutical firm to achieve $1-billion exports by Lee Han-soo 2019-12-05 15:04
라인
Roche Diabetes Care stresses ‘integrated personalized diabetes management’ by Park Gi-taek 2019-12-05 13:01
Macrogen’s research on Asian genomic database becomes cover story of Nature by Lee Han-soo 2019-12-05 11:54
‘Obesity treatment will drastically change next few years’ by Lee Han-soo 2019-12-04 18:20
'Insulin is safe, natural replacement therapy for diabetic patients' by Lee Han-soo 2019-12-04 17:07
SK Biopharm set to ensure superiority in antiepileptic drug by Jeong Sae-im 2019-12-04 16:18
라인
Hanmi licenses in US firm’s oral immunotherapy candidate by Lee Han-soo 2019-12-04 16:16
ISU Abxis starts trial of Gaucher disease treatment in Australia by Lee Han-soo 2019-12-04 16:16
Korean patient with rare breast cancer to sue Allergan in US by Song Soo-youn 2019-12-04 14:49
Drugmakers strongly oppose post-approval evaluation by Kim Eun-young 2019-12-04 13:17
Swedish researchers divide Type 2 diabetes into 5 subgroups by Lee Han-soo 2019-12-03 17:45
여백
여백
여백
Back to Top